The Dow Jones surged around 350 points on Thursday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Strata Skin Sciences (NASDAQ:SSKN) reported its Q4 earnings results on Monday, March 21, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Strata Skin Sciences reported in-line EPS of $-0.02 versus an estimate of $-0.02.
Strata Skin Sciences (NASDAQ:SSKN) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 100 percent decrease over losses of $(0.01) per share from the same period last year.
Companies Reporting Before The Bell
• Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million.
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment during the week.
Strata Skin Sciences (NASDAQ:SSKN) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement.
Analysts estimate that Strata Skin Sciences will report an earnings per share (EPS) of $-0.02.
Gainers
US Ecology, Inc. (NASDAQ: ECOL) shares surged 67.7% to close at $47.25 on Wednesday after Republic Services reported it will buy the company at $48 per share in cash.
Substantially broadens STRATA’s opportunity for expansion potential into the estimated $5.5 billion acne care market
Leverages STRATA’s innovative marketing platform, commercial team and